EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A Practical Roadmap for Clinical Translation of Metabolic Biomarkers: A Review

Kyung-Hee Kim, Maro Yoo, Min Yeong Choi iD, Byong Chul Yoo

International Journal of Molecular Sciences · 21.02.2026 · 27 (4) · 2030

DOI: 10.3390/ijms27042030 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.02.2026. Verfasst von Kyung-Hee Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Chemistry, School of Science and Technology, Kookmin University, Seoul 02707, Republic of Korea. Hauptthemen laut MEDLINE: Biomarkers, Metabolomics, Translational Research, Biomedical, Metabolome. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Ministry of Health & Welfare, Republic of Korea, Ministry of Health and Welfare, Republic of Korea, Kookmin University in Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolomics and lipidomics enable comprehensive profiling of metabolic states across diverse diseases and have generated a vast number of candidate biomarkers. Despite this progress, only a small fraction of metabolite-based biomarkers have achieved durable clinical translation. While this gap is often attributed to biological complexity or limited cohort size, increasing evidence suggests that failure more commonly reflects systematic misalignment between analytical measurement, biological interpretation, and clinical decision-making requirements. In this review, we argue that metabolites are not intrinsically unreliable biomarkers but are frequently overinterpreted as disease-specific indicators despite being highly context-dependent reporters of physiological state. We synthesize recurrent failure modes across the translational pipeline—including pre-analytical instability, ionization bias and semi-quantitative measurement, structural and annotation ambiguity, statistical overfitting, loss of disease specificity under systemic stress, and cohort-dependent performance collapse. Building on these insights, we propose a structured roadmap for the clinical translation of metabolite and lipid biomarkers. Rather than emphasizing further discovery, this framework prioritizes decision-oriented eligibility criteria encompassing pre-analytical robustness, analytical validity, molecular definition, biological interpretability, validation under real-world heterogeneity, and alignment with clinical utility and regulatory expectations. By reframing metabolic biomarkers as context-sensitive measurements embedded within clinical decision systems, this review provides practical guidance for investigators, clinicians, and regulators seeking to translate metabolomics and lipidomics into reliable tools for clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersMetabolomicsTranslational Research, BiomedicalMetabolomeHumansLipidomics

Stichwörter der Autor:innen

analytical validitybiomarker translationclinical validationcohort heterogeneitylipidomicsmetabolomicsmulti-metabolite panels

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Applied Chemistry, School of Science and Technology, Kookmin University, Seoul 02707, Republic of Korea.
  • Antibody Research Institute, Kookmin University, Seoul 02707, Republic of Korea.
  • Center for Liver and Pancreatobiliary Cancer, Hospital, National Cancer Center, Goyang 10408, Republic of Korea.
  • Division of Cancer Early Detection, National Cancer Control Institute, National Cancer Center, Goyang 10408, Republic of Korea.
  • Diagnostic Research Team, InnoBation Bio R&D Center, Seoul 03929, Republic of Korea.

ORCID-Profile: Min Yeong Choi

Förderung

  • the Ministry of Health & Welfare, Republic of Korea
  • Ministry of Health and Welfare, Republic of Korea
  • Kookmin University in Korea

Zitieren

APA

Kim, K. H., Yoo, M., Choi, M. Y., & Yoo, B. C. (2026). A Practical Roadmap for Clinical Translation of Metabolic Biomarkers: A Review. International Journal of Molecular Sciences, 27(4), 2030. https://doi.org/10.3390/ijms27042030

Vancouver

Kim KH, Yoo M, Choi MY, Yoo BC. A Practical Roadmap for Clinical Translation of Metabolic Biomarkers: A Review. International Journal of Molecular Sciences. 2026;27(4):2030. doi:10.3390/ijms27042030

BibTeX
@article{Kim2026,
  author = {Kim, Kyung-Hee and Yoo, Maro and Choi, Min Yeong and Yoo, Byong Chul},
  title = {A Practical Roadmap for Clinical Translation of Metabolic Biomarkers: A Review},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {4},
  pages = {2030},
  doi = {10.3390/ijms27042030}
}
Kostenlos starten →